Obermatt

IDEXX

NSQ:IDXX · US45168D1046
Health Care Equipment & SuppliesX-Large

360

76
EV / EBIT7
Price / Owner Earnings21
Owner Earnings Yield39
Dividend Yield1
Price/Sales22
EV / Gross Profit5
Price/Book7
Return on Capital100
Cash Return on Capital100
Return on Equity100
EBIT Margin98
Gross Profitability100
Cash Conversion6
Accruals48
Owner Earnings Margin95
Sales growth46
Profit Growth86
Long-Term EPS Growth63
Owner Earnings Growth64
Reinvestment78
Price momentum62
Debt load36
Refinancing35
Debt Payback60
Liquidity92
Analyst ratings18
Opinion Changes50
Price Target Upside66
Market mood100
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

IDEXX generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeNASDAQGS
Founded1983
Employees6,509
Websiteidexx.com
ISINUS45168D1046
Last UpdateApr 2, 2026
Themes
Animal FeedLivestockHematologyPet CareHealth DiagnosticsArtificial IntelligencePet Food and SuppliesSoftware DevelopmentHealth CareVeterinary

Description

IDEXX Laboratories, Inc. (IDEXX) develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. The company also manufactures and sell…

Analysis

Beloved champion

IDEXX Laboratories, Inc. is a beloved champion: its quality is genuine, and the market already prices it as exceptional. One caution: reported profits have recently run ahead of actual cash, which we track closely.

The price is expensive. You pay 39.3× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 15% yearly growth; analysts expect 12%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is sturdy. The company scores 18/20 on our value-creation score: strong value creator.

What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
77
2023202420252026

All-time high

80

Nov 2025

All-time low

7

Jan 2023

Average rank

50

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
22
13
3
13
Price/Earnings
15
23
13
15
Price/Book
7
4
1
3
Dividend Yield
1
1
1
1
Value (overall)
8
6
6
1

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare IDEXX with its peers
Abbott Laboratories
NYQ:ABT
41
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Quidel
NSQ:QDEL
9
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Fonar
NAQ:FONR
53
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Becton Dickinson
NYQ:BDX
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
GE Healthcare
NSQ:GEHC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →